EUVIMEDOpdag EUVIMED
Crossref

BRAF V600E mutation mediates invasive and growth features in ameloblastoma

Chen-Xi Zhang, Lin-Zhou Zhang, Hao Lin, Qi-Wen Man iD, Bing Liu iD

Oral Diseases · 2024

DOI: 10.1111/odi.14909 ↗

At a glance

Journal article in Oral Diseases, 2024. Written by Chen-Xi Zhang and 4 co-authors. Institution: State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Lab…. Major MEDLINE topics: Ameloblastoma, Proto-Oncogene Proteins B-raf, Neoplasm Invasiveness, Matrix Metalloproteinase 2. Cited 10 times so far (Crossref); 43 references. Funded by: National Natural Science Foundation of China.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Objectives

Ameloblastoma (AM), a locally aggressive tumor with extensive growth capacity, causes significant damage to the jaw and affects facial appearance. Although the high prevalence of BRAF V600E mutation in AM is known, its specific impacts on patients with AM remain unclear. Thus, the present study investigated the role of BRAF V600E mutation, thereby focusing on its impact on AM invasion and growth. Materials and Methods Immunohistochemical analysis was used to compare BRAF V600E, MMP2, MMP9, and Ki‐67 expressions in AM ( n = 49), normal oral mucosa (NOM) ( n = 10), and odontogenic keratocyst (OKC) ( n = 15) tissues. AM was further classified according to the presence or absence of BRAF V600E. The relationship between BRAF V600E and invasion as well as growth was evaluated. In addition, correlation analysis was performed using immunohistochemistry and confirmed via double‐labeling immunofluorescence. Finally, comparative analyses using mass spectrometry, immunohistochemistry, and immunofluorescence were performed to explore and identify underlying mechanisms.

Results

AM exhibited a higher incidence of BRAF V600E mutation than NOM and OKC. BRAF V600E expression was positively correlated with the invasion‐associated proteins MMP2 and MMP9 and the growth‐related protein Ki‐67. Proteomic data revealed that BRAF V600E primarily activates the MAPK signaling pathway in AM, particularly driving the phosphorylation of extracellular signal‐regulated kinase 1/2 (ERK1/2).

Conclusions

In summary, the findings suggested that the BRAF V600E mutation enhances the invasion and growth abilities of AM via the MAPK/ERK signaling pathway. Thus, targeting BRAF V600E or the MAPK/ERK pathway may be a potential AM therapy.

Subjects

MeSH terms (MEDLINE)

AmeloblastomaProto-Oncogene Proteins B-rafNeoplasm InvasivenessMatrix Metalloproteinase 2MutationMatrix Metalloproteinase 9HumansFemaleMaleMiddle AgedAdultJaw NeoplasmsKi-67 AntigenOdontogenic CystsMAP Kinase Signaling SystemYoung AdultAgedMouth MucosaAdolescent

Author keywords

BRAF proteinKi‐67 antigenMAP kinase signaling systemameloblastomaneoplasm invasiveness

Substances

Proto-Oncogene Proteins B-rafBRAF protein, humanMatrix Metalloproteinase 2Matrix Metalloproteinase 9MMP2 protein, humanKi-67 AntigenMMP9 protein, human

Authors and institutions

  • State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan Univer…
  • Department of Oral Maxillofacial Head Neck Oncology, School and Hospital of Stomatology, Wuhan University, Wuhan, China.

ORCID profiles: Qi-Wen Man, Bing Liu

Funding

  • National Natural Science Foundation of China

Cite

APA

Zhang, C. X., Zhang, L. Z., Lin, H., Man, Q. W., & Liu, B. (2024). BRAF V600E mutation mediates invasive and growth features in ameloblastoma. Oral Diseases. https://doi.org/10.1111/odi.14909

Vancouver

Zhang CX, Zhang LZ, Lin H, Man QW, Liu B. BRAF V600E mutation mediates invasive and growth features in ameloblastoma. Oral Diseases. 2024. doi:10.1111/odi.14909

BibTeX
@article{Zhang2024,
  author = {Zhang, Chen-Xi and Zhang, Lin-Zhou and Lin, Hao and Man, Qi-Wen and Liu, Bing},
  title = {BRAF V600E mutation mediates invasive and growth features in ameloblastoma},
  journal = {Oral Diseases},
  year = {2024},
  doi = {10.1111/odi.14909}
}
Start for free →